Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-29

Clinical Trial Update: Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation [NA]

View source ↗

Summary

A clinical trial update shows recruitment for cortical neuromodulation to reduce auditory-verbal hallucinations in schizophrenia. The study targets treatment-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier St Anne | Conditions: Treatment Resistant Schizophrenia | NA | Status: RECRUITING